| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6200987 | Ophthalmology | 2015 | 12 Pages |
Abstract
In patients with macular edema resulting from RVO, there was no short-term clinically significant benefit from monthly injections of 2.0-mg versus 0.5-mg ranibizumab injections and no long-term benefit in BCVA, resolution of edema, or number of ranibizumab injections obtained by addition of laser treatment to ranibizumab.
Keywords
RBZBRVOAMDCRVOPRNRVOBCVACStBranch retinal vein occlusionRetinal vein occlusionCentral retinal vein occlusionOctbest-corrected visual acuityOptical coherence tomographyranibizumabage-related macular degenerationcentral subfield thicknesspro re nataVascular endothelial growth factorVascular Endothelial Growth Factor (VEGF)
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Peter A. MD, Gulnar MD, Tahreem A. MD, Adrienne W. MD, Sharon MD, Ingrid MD, Akrit MD, PhD, Elia MD, Howard MD, PhD, Adam MD, PhD, Syed Mahmood MD, Diana V. MD, Quan D. MD, Saleema MD, Raafay MD,